Carly E. Whyte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carly E. Whyte has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Liston
The Babraham Institute, Immunology Programme, Cambridge, UK
5 shared publications - Carlos P. Roca
B Department of Chemical Engineering , Universitat Rovira i Virgili , Tarragona , Spain
3 shared publications - James Dooley
Translational Immunology Laboratory, VIB, Leuven, Belgium
3 shared publications - Oliver T. Burton
Department of Pathology, University of Cambridge, Cambridge, UK
3 shared publications Teresa Prezzemolo
VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
3 shared publications- Alena Moudra
Institute of Molecular Genetics of the Czech Academy of Sciences
2 shared publications
Latest Publications
- Open Access
- 14 June 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (7)
Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits
Interleukin 2 (IL-2) is a key homeostatic cytokine, with therapeutic applications in both immunogenic and tolerogenic immune modulation. Clinical use has been hampered by pleiotropic functionality and widespread receptor expression, with unexpected adverse events. Here, we developed a novel mouse strain to divert IL-2 production, allowing identification of contextual outcomes. Network analysis identified priority access for Tregs and a competitive fitness cost of IL-2 production among both Tregs and conventional CD4 T cells. CD8 T and NK cells, by contrast, exhibited a preference for autocrine IL-2 production. IL-2 sourced from dendritic cells amplified Tregs, whereas IL-2 produced by B cells induced two context-dependent circuits: dramatic expansion of CD8+ Tregs and ILC2 cells, the latter driving a downstream, IL-5–mediated, eosinophilic circuit. The source-specific effects demonstrate the contextual influence of IL-2 function and potentially explain adverse effects observed during clinical trials. Targeted IL-2 production therefore has the potential to amplify or quench particular circuits in the IL-2 network, based on clinical desirability.
- 14 June 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (7)
Open AccessContext-dependent effects of IL-2 rewire immunity into distinct cellular circuits
Interleukin 2 (IL-2) is a key homeostatic cytokine, with therapeutic applications in both immunogenic and tolerogenic immune modulation. Clinical use has been hampered by pleiotropic functionality and widespread receptor expression, with unexpected adverse events. Here, we developed a novel mouse strain to divert IL-2 production, allowing identification of contextual outcomes. Network analysis identified priority access for Tregs and a competitive fitness cost of IL-2 production among both Tregs and conventional CD4 T cells. CD8 T and NK cells, by contrast, exhibited a preference for autocrine IL-2 production. IL-2 sourced from dendritic cells amplified Tregs, whereas IL-2 produced by B cells induced two context-dependent circuits: dramatic expansion of CD8+ Tregs and ILC2 cells, the latter driving a downstream, IL-5–mediated, eosinophilic circuit. The source-specific effects demonstrate the contextual influence of IL-2 function and potentially explain adverse effects observed during clinical trials. Targeted IL-2 production therefore has the potential to amplify or quench particular circuits in the IL-2 network, based on clinical desirability.
- Top Cited PapersOpen Access
- 26 May 2022
- Published by Springer Nature in Nature Immunology
- Vol. 23 (6) , 878-891
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation
The ability of immune-modulating biologics to prevent and reverse pathology has transformed recent clinical practice. Full utility in the neuroinflammation space, however, requires identification of both effective targets for local immune modulation and a delivery system capable of crossing the blood–brain barrier. The recent identification and characterization of a small population of regulatory T (Treg) cells resident in the brain presents one such potential therapeutic target. Here, we identified brain interleukin 2 (IL-2) levels as a limiting factor for brain-resident Treg cells. We developed a gene-delivery approach for astrocytes, with a small-molecule on-switch to allow temporal control, and enhanced production in reactive astrocytes to spatially direct delivery to inflammatory sites. Mice with brain-specific IL-2 delivery were protected in traumatic brain injury, stroke and multiple sclerosis models, without impacting the peripheral immune system. These results validate brain-specific IL-2 gene delivery as effective protection against neuroinflammation, and provide a versatile platform for delivery of diverse biologics to neuroinflammatory patients.
- 26 May 2022
- Published by Springer Nature in Nature Immunology
- Vol. 23 (6) , 878-891
Top Cited PapersOpen AccessAstrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation
The ability of immune-modulating biologics to prevent and reverse pathology has transformed recent clinical practice. Full utility in the neuroinflammation space, however, requires identification of both effective targets for local immune modulation and a delivery system capable of crossing the blood–brain barrier. The recent identification and characterization of a small population of regulatory T (Treg) cells resident in the brain presents one such potential therapeutic target. Here, we identified brain interleukin 2 (IL-2) levels as a limiting factor for brain-resident Treg cells. We developed a gene-delivery approach for astrocytes, with a small-molecule on-switch to allow temporal control, and enhanced production in reactive astrocytes to spatially direct delivery to inflammatory sites. Mice with brain-specific IL-2 delivery were protected in traumatic brain injury, stroke and multiple sclerosis models, without impacting the peripheral immune system. These results validate brain-specific IL-2 gene delivery as effective protection against neuroinflammation, and provide a versatile platform for delivery of diverse biologics to neuroinflammatory patients.
- Open Access
- 17 May 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data
Compensating in flow cytometry is an unavoidable challenge in the data analysis of fluorescence-based flow cytometry. Even the advent of spectral cytometry cannot circumvent the spillover problem, with spectral unmixing an intrinsic part of such systems. The calculation of spillover coefficients from single-color controls has remained essentially unchanged since its inception, and is increasingly limited in its ability to deal with high-parameter flow cytometry. Here, we present AutoSpill, an alternative method for calculating spillover coefficients. The approach combines automated gating of cells, calculation of an initial spillover matrix based on robust linear regression, and iterative refinement to reduce error. Moreover, autofluorescence can be compensated out, by processing it as an endogenous dye in an unstained control. AutoSpill uses single-color controls and is compatible with common flow cytometry software. AutoSpill allows simpler and more robust workflows, while reducing the magnitude of compensation errors in high-parameter flow cytometry.
- 17 May 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Open AccessAutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data
Compensating in flow cytometry is an unavoidable challenge in the data analysis of fluorescence-based flow cytometry. Even the advent of spectral cytometry cannot circumvent the spillover problem, with spectral unmixing an intrinsic part of such systems. The calculation of spillover coefficients from single-color controls has remained essentially unchanged since its inception, and is increasingly limited in its ability to deal with high-parameter flow cytometry. Here, we present AutoSpill, an alternative method for calculating spillover coefficients. The approach combines automated gating of cells, calculation of an initial spillover matrix based on robust linear regression, and iterative refinement to reduce error. Moreover, autofluorescence can be compensated out, by processing it as an endogenous dye in an unstained control. AutoSpill uses single-color controls and is compatible with common flow cytometry software. AutoSpill allows simpler and more robust workflows, while reducing the magnitude of compensation errors in high-parameter flow cytometry.
- Top Cited PapersOpen Access
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition
Top Cited PapersOpen AccessMicroglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition
- Open Access
- 24 April 2020
- Published by Wiley in Immunology & Cell Biology
- Vol. 98 (5) , 349-350
Bile acids mediate signaling between microbiome and the immune system
- 24 April 2020
- Published by Wiley in Immunology & Cell Biology
- Vol. 98 (5) , 349-350
Open AccessBile acids mediate signaling between microbiome and the immune system
- Open Access
- 14 April 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (6)
ACKR4 restrains antitumor immunity by regulating CCL21
Current immunotherapies involving CD8+ T cell responses show remarkable promise, but their efficacy in many solid tumors is limited, in part due to the low frequency of tumor-specific T cells in the tumor microenvironment (TME). Here, we identified a role for host atypical chemokine receptor 4 (ACKR4) in controlling intratumor T cell accumulation and activation. In the absence of ACKR4, an increase in intratumor CD8+ T cells inhibited tumor growth, and nonhematopoietic ACKR4 expression was critical. We show that ACKR4 inhibited CD103+ dendritic cell retention in tumors through regulation of the intratumor abundance of CCL21. In addition, preclinical studies indicate that ACKR4 and CCL21 are potential therapeutic targets to enhance responsiveness to immune checkpoint blockade or T cell costimulation.
- 14 April 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (6)
Open AccessACKR4 restrains antitumor immunity by regulating CCL21
Current immunotherapies involving CD8+ T cell responses show remarkable promise, but their efficacy in many solid tumors is limited, in part due to the low frequency of tumor-specific T cells in the tumor microenvironment (TME). Here, we identified a role for host atypical chemokine receptor 4 (ACKR4) in controlling intratumor T cell accumulation and activation. In the absence of ACKR4, an increase in intratumor CD8+ T cells inhibited tumor growth, and nonhematopoietic ACKR4 expression was critical. We show that ACKR4 inhibited CD103+ dendritic cell retention in tumors through regulation of the intratumor abundance of CCL21. In addition, preclinical studies indicate that ACKR4 and CCL21 are potential therapeutic targets to enhance responsiveness to immune checkpoint blockade or T cell costimulation.
- 1 November 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (41)
A divergent transcriptional landscape underpins the development and functional branching of MAIT cells
Characterizing MAIT cell development led to the identification of key regulators that specify MAIT cell fate in the thymus.
- 1 November 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (41)
A divergent transcriptional landscape underpins the development and functional branching of MAIT cells
Characterizing MAIT cell development led to the identification of key regulators that specify MAIT cell fate in the thymus.